Monitoring of an older male patient on testosterone replacement includes 1

Monitoring of an older male patient on testosterone

This preview shows page 27 - 29 out of 29 pages.

Monitoring of an older male patient on testosterone replacement includes: 1. Oxygen saturation levels at every visit 2. Serum cholesterol and lipid profile every 3 to 6 months 3. Digital rectal prostate screening exam at 3 and 6 months after starting therapy 4. Bone mineral density at 3 months and 6 months after starting therapy ____ 7. When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of: 1. Statins 2. Nitrates 3. Insulin 4. Opioids ____ 8. Men who are prescribed phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include: 1. Hearing loss 2. Hypotension 3. Delayed ejaculation 4. Dizziness ____ 9. Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5) inhibitors include: 1. Diabetics 2. Those who have had an acute myocardial infarction in the past 6 months 3. Patients who are deaf Copyright © 2016 F. A. Davis Company
Image of page 27
4. Patients under age 60 years of age ____ 10. Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5) inhibitors includes: 1. Serum fasting glucose levels 2. Cholesterol and lipid levels 3. Blood pressure 4. Complete blood count Copyright © 2016 F. A. Davis Company
Image of page 28
Chapter 49. Men as Patients Answer Section MULTIPLE CHOICE 1. ANS: 4 PTS: 1 2. ANS: 2 PTS: 1 3. ANS: 4 PTS: 1 4. ANS: 2 PTS: 1 5. ANS: 4 PTS: 1 6. ANS: 3 PTS: 1 7. ANS: 2 PTS: 1 8. ANS: 1 PTS: 1 9. ANS: 2 PTS: 1 10. ANS: 3 PTS: 1 Copyright © 2016 F. A. Davis Company
Image of page 29

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture